''MetaReg": A new journey just begins!

Our project "MetaReg" was selected among the 300 Proof of Concept Grants to be funded under the European Research Council (ERC) 2025 work programme.

The ERC PoC will support us in exploring how mechanistic targeting of the safeguards of our immune system, namely regulatory T cells, can move towards practical application or early commercial use, enabling next-gen therapy in cancer without the risk of autoimmune toxicities.